| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |